Mansour A. Alkhunaizi(23) |
HVAD 2 |
2 years after insertion |
2 months
of worsening fatigue, dark cola-colored urine, and 1 day of low-flow
alarms from her HVAD. |
TTE was performed, which showed a lack of
Doppler flow through the HVAD |
no |
pump exchange |
survive |
Pendyal A (24) |
HM II |
3 years later with previous 3 episodes of
thrombosis |
dark urine |
TTE |
no |
heart transplantation |
survive |
Hubbert, L. (25) |
HM II |
|
short of breath on mild exertion |
CTA |
no |
endovascular stenting |
develop SAH 1 week later but
survive |
Rajapreyar (26) |
HeartWare LVAD |
1 year after |
elevated power, high
LVAD flows, dark urine |
|
no |
pump exchange |
Comfort care measures
were instituted and LVAD therapy was discontinued as per patient and
family wishes |
Rajapreyar (27) |
HeartWare LVAD |
2 years after |
elevated LVAD flows
>10, power and laboratory parameters of hemolysis |
|
no |
pump exchange |
survived |
Dobner S (28) |
HVAD 2 |
5 recurrent pump thrombosis at 4,6,12,13,14
months respond to medical thrombolysis |
Hematuria |
|
no |
change
device to HM III |
survived |
(28) |
HM III |
6 months after |
VAD alarms pointed towards a VAD pump
thrombosis |
CTA |
no |
surgical revision of the outflow graft |
survived |
Sivathasan (29) |
HM II |
4 months later |
dyspnea |
TTE |
no |
later
heart transplantation |
survived |
Bunge, Jeroen J. H (30) |
HM III |
3 days after insertion |
Signs of
cardiogenic shock and acute respiratory failure |
TTE and CTA |
no |
urgent HM3 pump and outflow graft replacement |
survived |